Patients taking the drugs for obesity had a 41% lower risk of related cancers

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or…

A new wave of research links GLP-1 drugs to reduced cancer spread and better survival, and the mechanism may go beyond just weight loss

Patients taking the drugs for obesity had a 41% lower risk of related cancers

GLP-1s may be able to alter the body’s inflammatory and metabolic environment making cancer therapies more effective. Clinical trials will be the next step.